These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 17105987)

  • 41. Body mass index and risk of malignant lymphoma in Scandinavian men and women.
    Chang ET; Hjalgrim H; Smedby KE; Akerman M; Tani E; Johnsen HE; Glimelius B; Adami HO; Melbye M
    J Natl Cancer Inst; 2005 Feb; 97(3):210-8. PubMed ID: 15687364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
    J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
    Motamedinia P; Korets R; Spencer BA; Benson MC; McKiernan JM
    Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of BMI on primary treatment of prostate cancer.
    Davies BJ; Walsh TJ; Ross PL; Knight SJ; Sadetsky N; Carroll PR; Kane CJ
    Urology; 2008 Aug; 72(2):406-11. PubMed ID: 18267336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
    Gennari A; Sormani MP; Pronzato P; Puntoni M; Colozza M; Pfeffer U; Bruzzi P
    J Natl Cancer Inst; 2008 Jan; 100(1):14-20. PubMed ID: 18159072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
    Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
    Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
    Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
    Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy.
    Gertler R; Rosenberg R; Schuster T; Friess H
    Eur J Cancer; 2009 Nov; 45(17):2992-9. PubMed ID: 19682890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of body mass index on the outcome of patients with rectal cancer receiving curative anterior resection: disparity between the upper and lower rectum.
    You JF; Tang R; Changchien CR; Chen JS; You YT; Chiang JM; Yeh CY; Hsieh PS; Tsai WS; Fan CW; Hung HY
    Ann Surg; 2009 May; 249(5):783-7. PubMed ID: 19387325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Body mass index in relation to ovarian cancer survival.
    Zhang M; Xie X; Lee AH; Binns CW; Holman CD
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1307-10. PubMed ID: 15894691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery.
    Mullen JT; Moorman DW; Davenport DL
    Ann Surg; 2009 Jul; 250(1):166-72. PubMed ID: 19561456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care.
    Buist DS; Ichikawa L; Prout MN; Yood MU; Field TS; Owusu C; Geiger AM; Quinn VP; Wei F; Silliman RA
    J Clin Oncol; 2007 Aug; 25(23):3428-36. PubMed ID: 17687148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of obesity on survival in patients with ovarian cancer.
    Matthews KS; Straughn JM; Kemper MK; Hoskins KE; Wang W; Rocconi RP
    Gynecol Oncol; 2009 Feb; 112(2):389-93. PubMed ID: 19062080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries.
    Abdulla J; Køber L; Abildstrøm SZ; Christensen E; James WP; Torp-Pedersen C
    Eur Heart J; 2008 Mar; 29(5):594-601. PubMed ID: 18270214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study.
    Park SM; Lim MK; Shin SA; Yun YH
    J Clin Oncol; 2006 Nov; 24(31):5017-24. PubMed ID: 17075121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship of body mass index to outcomes after percutaneous coronary intervention.
    Shubair MM; Prabhakaran P; Pavlova V; Velianou JL; Sharma AM; Natarajan MK
    J Interv Cardiol; 2006 Oct; 19(5):388-95. PubMed ID: 17020562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.